KLRG1 and cancer: KLRG1 has demonstrated significant antitumor and inhibitory effects on tumor growth in a wide range of malignant tumors, while KLRG1-targeted inhibitors have also been developed as tumor immunotherapies and have been a popular area of research in immunotherapy [8, 23–25].